ArticleCancer2013

UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.

Peter E Zage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.